Keyphrases
Therapeutic Agents
100%
Methylene Blue
100%
Ataxia
100%
Mitochondrial Therapeutics
100%
Friedreich Ataxia
85%
Frataxin
42%
Oxidative Stress
14%
Mitochondrial Function
14%
Oral Bioavailability
14%
Metabolic Stability
14%
Drugability
14%
Pharmacokinetic Profile
14%
Preclinical Development
14%
Methylene Violet
14%
Oral Administration
14%
Model Stability
14%
Hereditary Neurodegenerative Diseases
14%
Effective Therapy
14%
Cellular Models
14%
Lymphocytes
14%
Pharmacology, Toxicology and Pharmaceutical Science
Ataxia
100%
Carbene
100%
Friedreich's Ataxia
85%
Frataxin
42%
Mouse
28%
New Methylene Blue
14%
Bioavailability
14%
Pharmacokinetics
14%
Degenerative Disease
14%